| 1 |
33460524 | Body-weight-independent glucose-lowering effect of the β3-adrenergic receptor agonist mirabegron in humans. | 2021 May |
1 |
| 2 |
32813332 | The metabolic effects of mirabegron are mediated primarily by β3 -adrenoceptors. | 2020 Oct |
1 |
| 3 |
23818156 | Mirabegron: a review of its use in patients with overactive bladder syndrome. | 2013 Jul |
3 |
| 4 |
17293563 | Effect of (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function. | 2007 May |
2 |